BioAdaptives, Inc. (BDPT)
OTCMKTS · Delayed Price · Currency is USD
0.0303
+0.0030 (11.01%)
Oct 24, 2025, 12:34 PM EDT
BioAdaptives Revenue
BioAdaptives had revenue of $3.22K in the quarter ending June 30, 2025, with 376.89% growth. This brings the company's revenue in the last twelve months to $3.22K, down -90.94% year-over-year. In the year 2024, BioAdaptives had annual revenue of $12.67K, down -55.65%.
Revenue (ttm)
3.22K
Revenue Growth
-90.94%
P/S Ratio
112.85
Revenue / Employee
3.22K
Employees
1
Market Cap
363.26K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.67K | -15.90K | -55.65% |
| Dec 31, 2023 | 28.57K | 11.39K | 66.31% |
| Dec 31, 2022 | 17.18K | -2.60K | -13.15% |
| Dec 31, 2021 | 19.78K | 3.45K | 21.12% |
| Dec 31, 2020 | 16.33K | 6.39K | 64.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| South Dakota Soybean Processors, LLC | 485.00M |
| Cuisine Solutions | 80.48M |
| Armanino Foods of Distinction | 73.15M |
| Crimson Wine Group | 71.27M |
| Golden Growers Cooperative | 70.82M |
| Hongchang International | 29.45M |
| Microalliance Group | 22.88M |
| ESG Inc. | 11.87M |
BioAdaptives News
- 18 days ago - BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing - GlobeNewsWire
- 2 months ago - BioAdaptives' MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety - GlobeNewsWire
- 3 months ago - BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience - GlobeNewsWire
- 4 months ago - BioAdaptives Announces National Launch of Pawpa™ Regen - GlobeNewsWire
- 5 months ago - BioAdaptives® PawPa™ Regen Provides Breakthrough Stem Cell Support for Pets, Backed by Clinically Proven APBAR® Scale Improvements - GlobeNewsWire
- 8 months ago - Zeranovia(TM) Weight Loss Product Shows Promising Results in Dosage Trial - GlobeNewsWire
- 9 months ago - BioAdaptives Welcomes UFC Senior Executive Reed Harris to Its Board of Advisors - GlobeNewsWire
- 9 months ago - BioAdaptives Welcomes Mark Frissora, Acclaimed Business Leader, to Its Board of Directors - GlobeNewsWire